| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |